Amedisys’ (Nasdaq: AMED) planned divestiture of more than 100 home health and hospice locations to VitalCaring has reportedly been halted following a federal court ruling that requires Texas-based VitalCaring to allocate a significant portion of its future profits to Encompass Health and Enhabit. Amedisys in June announced an agreement to sell some of its locations […]
Major deals hit snags. Home health cuts continued. Regulatory noise came in from all sides, in Medicare and in Medicaid. All of those realities made their way into Home Health Care News’ most popular stories for the year. In order to summarize the 2024 that providers had, HHCN is revisiting 10 of its most widely […]
A federal judge in Delaware has ordered home health and hospice provider VitalCaring and its private equity backers to share future profits with Encompass Health (NYSE: EHC) and Enhabit Inc. (NYSE: EHAB). The court ordered that 43% of VitalCaring’s future profits be placed in trust to benefit Encompass and Enhabit. The remaining 57% would go […]
VitalCaring Group – the home health and hospice company led by April Anthony – got caught in the crosshairs of the U.S. Department of Justice (DOJ) this week. The company responded, however, defending its current state and re-emphasizing where it plans to go. VitalCaring agreed to acquire divested assets from Amedisys Inc. (Nasdaq: AMED) in […]
VitalCaring has announced the results of a seven-month AI-driven cognitive care pilot program. The program provided personalized therapy to patients with cognitive disorders using Constant Therapy’s digital speech, language and cognitive therapy platform as part of its home-based services for selected patients. Based in Dallas, VitalCaring provides home health and hospice care to patients in […]
It’s the interest rate, stupid. Home health, home care and hospice industry voices – including myself – have regularly pointed toward internal factors affecting M&A over the last two and a half years. In the end, the overarching, main headwind was always the extremely high interest rates that were put forth by the Federal Reserve […]
Amedisys Inc. (Nasdaq: AMED) is waiting for multiple big-time transactions to come to fruition by year end. In the meantime, it continues to grow its non-Medicare revenue and its high-acuity care business considerably. The company released its second-quarter earnings on Wednesday, without an accompanying call. It has not held an official earnings call since UnitedHealth […]
On late Friday, Amedisys Inc. (Nasdaq: AMED) announced that it had agreed to divest certain locations to VitalCaring, in a deal that would be a massive one for the home health industry. It could clear the way for UnitedHealth Group (NYSE: UNH) to finalize its takeover of Amedisys, and also turn VitalCaring into one of […]
Amedisys Inc. (Nasdaq: AMED) filed paperwork Friday with the U.S. Securities and Exchange Commission saying it has agreed to divest “certain” locations to an affiliate of home health and hospice company VitalCaring. The divestiture was a way for Amedisys to avoid further antitrust concerns from regulators prior to it joining UnitedHealth Group (NYSE: UNH). UnitedHealth […]
The Centers for Medicare & Medicaid Services’ (CMS) proposed home health payment rule, released Wednesday, included significant cuts for the third straight year. Those cuts, among other proposed changes, raise questions over the stability of the industry in the coming years. It has providers asking themselves and others the question: “Why us?” For an industry […]
By continuing to use the site, you agree to the use of cookies. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. For more information, see our cookie policy
